Introduction This study examined the prevalence of financial toxicity (FT) its association with health-related quality of life (HRQoL). Methods Study design: Cross-sectional, 1st May – 30 Nov. 2018. Total sample size: 429. Sampling method: Universal sampling. Study sites: Urology clinics of Sarawak General Hospital (n = 366) and Subang Jaya Medical Centre (n = 63). Instrument and validity: Subjective financial toxicity 0.804, Objective financial toxicity n/a, Health-related Quality of Life 0.995.Data collection: Interviewer-administered questionnaire. Data analysis: SPSS V22. Results [Refer to Poster]. Discussion / Conclusion Objective and subjective FT were experienced by 16.1 and 47.3% of the respondents, respectively. Greater objectiv...
Aim: The very high cost of modern cancer treatments is raising the issue of health systems and indiv...
Purpose The aim of this study was to examine the relationship between employment and financial toxic...
Background Financial toxicity has traditionally been attributed to the rising costs of cancer care. ...
Purpose: This study examined the prevalence of financial toxicity (FT) and associated factors among ...
purpose: we investigated the association of financial toxicity (FT) with the health-related quality ...
Purpose: Costly surveillance and treatment of bladder cancer can lead to financial toxicity, a treat...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
ABSTRACT Objective: to assess the financial toxicity of people with chronic kidney disease undergoi...
BackgroundIn the US, medical costs for cancer patients have grown from $27 billion in 1990 to $174 b...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Objective To determine the extent of financial toxicity (FT) among cancer survivors, identify the de...
Objective: To determine the extent of financial toxicity (FT) among cancer survivors, identify the ...
Objective: To determine the extent of financial toxicity (FT) among cancer survivors, identify the d...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: The aim of this stud...
Aim: The very high cost of modern cancer treatments is raising the issue of health systems and indiv...
Purpose The aim of this study was to examine the relationship between employment and financial toxic...
Background Financial toxicity has traditionally been attributed to the rising costs of cancer care. ...
Purpose: This study examined the prevalence of financial toxicity (FT) and associated factors among ...
purpose: we investigated the association of financial toxicity (FT) with the health-related quality ...
Purpose: Costly surveillance and treatment of bladder cancer can lead to financial toxicity, a treat...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
ABSTRACT Objective: to assess the financial toxicity of people with chronic kidney disease undergoi...
BackgroundIn the US, medical costs for cancer patients have grown from $27 billion in 1990 to $174 b...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Objective To determine the extent of financial toxicity (FT) among cancer survivors, identify the de...
Objective: To determine the extent of financial toxicity (FT) among cancer survivors, identify the ...
Objective: To determine the extent of financial toxicity (FT) among cancer survivors, identify the d...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: The aim of this stud...
Aim: The very high cost of modern cancer treatments is raising the issue of health systems and indiv...
Purpose The aim of this study was to examine the relationship between employment and financial toxic...
Background Financial toxicity has traditionally been attributed to the rising costs of cancer care. ...